Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Posch

Showing results (791-800 of 1,203) with videos related to

Pageof 121
Sort By:
Plos One|July 26, 2016
Blood-Based Biomarkers Are Associated with Disease Recurrence and Survival in Gastrointestinal Stroma Tumor Patients after Surgical ResectionMichael Stotz, Bernadette Liegl-Atzwanger, Florian Posch, et al.
Somatosensory & Motor Research|July 6, 2017
Utility of nociceptive flexion reflex threshold and bispectral index to predict movement responses under propofol anaesthesiaAxel Jakuscheit, Matthias J Posch, Stefanos Gkaitatzis, et al.
Scientific Reports|February 22, 2020
Evaluation of T1 relaxation time in prostate cancer and benign prostate tissue using a Modified Look-Locker inversion recovery sequenceAlexander D J Baur, Carla M Hansen, Julian Rogasch, et al.
Eclinicalmedicine|January 16, 2024
Current state-of-the-art and gaps in platform trials: 10 things you should know, insights from EU-PEARLFranz Koenig, Cécile Spiertz, Daniel Millar, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 4, 2020
Modifiable Risk Factors for the Emergence of Ceftolozane-tazobactam ResistancePranita D Tamma, Stephan Beisken, Yehudit Bergman, et al.
Pharmaceutical Statistics|August 27, 2025
Design Considerations for a Phase II Platform Trial in Major Depressive DisorderMichaela Maria Freitag, Dario Zocholl, Elias Laurin Meyer, et al.
Journal of Fungi (Basel, Switzerland)|February 25, 2022
COVID-19 Associated Pulmonary Aspergillosis: Diagnostic Performance, Fungal Epidemiology and Antifungal SusceptibilityNina Lackner, Claudius Thomé, Dietmar Öfner, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 14, 1999
Specific recognition of HLA-E, but not classical, HLA class I molecules by soluble CD94/NKG2A and NK cellsA G Brooks, F Borrego, P E Posch, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|September 24, 2011
Emergence of carbapenem-resistant Enterobacteriaceae in Austria, 2001-2010G Zarfel, M Hoenigl, B Würstl, et al.
Clinical and Experimental Rheumatology|October 23, 2020
Ianalumab (VAY736) in primary Sjögren's syndrome: assessing disease activity using multi-modal ultrasoundTorsten Diekhoff, Thomas Fischer, Quirino Schefer, et al.
Pageof 121

Showing results (791-800 of 1,203) with videos related to

Sort By:
Pageof 121
Plos One|July 26, 2016
Blood-Based Biomarkers Are Associated with Disease Recurrence and Survival in Gastrointestinal Stroma Tumor Patients after Surgical ResectionMichael Stotz, Bernadette Liegl-Atzwanger, Florian Posch, et al.
Somatosensory & Motor Research|July 6, 2017
Utility of nociceptive flexion reflex threshold and bispectral index to predict movement responses under propofol anaesthesiaAxel Jakuscheit, Matthias J Posch, Stefanos Gkaitatzis, et al.
Scientific Reports|February 22, 2020
Evaluation of T1 relaxation time in prostate cancer and benign prostate tissue using a Modified Look-Locker inversion recovery sequenceAlexander D J Baur, Carla M Hansen, Julian Rogasch, et al.
Eclinicalmedicine|January 16, 2024
Current state-of-the-art and gaps in platform trials: 10 things you should know, insights from EU-PEARLFranz Koenig, Cécile Spiertz, Daniel Millar, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 4, 2020
Modifiable Risk Factors for the Emergence of Ceftolozane-tazobactam ResistancePranita D Tamma, Stephan Beisken, Yehudit Bergman, et al.
Pharmaceutical Statistics|August 27, 2025
Design Considerations for a Phase II Platform Trial in Major Depressive DisorderMichaela Maria Freitag, Dario Zocholl, Elias Laurin Meyer, et al.
Journal of Fungi (Basel, Switzerland)|February 25, 2022
COVID-19 Associated Pulmonary Aspergillosis: Diagnostic Performance, Fungal Epidemiology and Antifungal SusceptibilityNina Lackner, Claudius Thomé, Dietmar Öfner, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 14, 1999
Specific recognition of HLA-E, but not classical, HLA class I molecules by soluble CD94/NKG2A and NK cellsA G Brooks, F Borrego, P E Posch, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|September 24, 2011
Emergence of carbapenem-resistant Enterobacteriaceae in Austria, 2001-2010G Zarfel, M Hoenigl, B Würstl, et al.
Clinical and Experimental Rheumatology|October 23, 2020
Ianalumab (VAY736) in primary Sjögren's syndrome: assessing disease activity using multi-modal ultrasoundTorsten Diekhoff, Thomas Fischer, Quirino Schefer, et al.
Pageof 121